返回 $name
Session Chair(s)
Stacy Tegan
Program Director
Transcelerate Biopharma, Inc., United States
Speaker(s)
FDA Perspective of the Protocol Template
Ron Fitzmartin, PhD, MBA
FDA, United States
Senior Informatics Advisor, Office of Regulatory Operations, CBER
The Common Protocol Template: Common Structure, Common Language, Uncommon Benefits to End Users
Robert DiCicco, PharmD
TransCelerate Biopharma Inc., United States
Vice President, Portfolio Management
The Common Protocol Template: Foundation for the Future
Robert L. Ferendo
Eli Lilly and Company, United States
Consultant-Process & Technology